| Heart Failure (HF) |
1 |
1 |
| Heart |
0 |
0.72 |
| COVID-19 |
0 |
0.68 |
| Hypertension |
0 |
0.52 |
| Pandemic |
0 |
0.51 |
| Artery |
0 |
0.29 |
| Europe |
0 |
0.22 |
| Hemodynamics |
0 |
0.2 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Adherence |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| California |
0 |
0.07 |
| Colorado |
0 |
0.07 |
| Diuretics |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| New York |
0 |
0.07 |
| Patient Assessment |
0 |
0.07 |
| Professional Societies |
0 |
0.07 |
| Respiratory Tract Infections |
0 |
0.07 |
| Severe Acute Respiratory Syndrome |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Tennessee |
0 |
0.07 |